W. Mark Watson - 04 Aug 2022 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Role: Director
Signature: /s/ Edward Berg, Attorney-in-Fact for W. Mark Watson
Issuer symbol: VXRT
Transactions as of: 04 Aug 2022
Net transactions value: $0
Form type: 4
Filing time: 08 Aug 2022, 18:39:08 UTC
Previous filing: 14 Jun 2022
Next filing: 28 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VXRT	Common Stock	Award	$0	+14,750		$0.000000	14,750	04 Aug 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VXRT	Stock Option (right to buy)	Award	$0	+88,448		$0.000000	88,448	04 Aug 2022	Common Stock	88,448	$3.91	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of shares upon vesting of restricted stock units. One third of the shares underlying the award shall vest on each anniversary of the grant date, so that the restricted stock units would be fully vested on the third anniversary of the grant date.
F2	The shares subject to this option shall vest annually over three years from the vesting commencement date of August 4, 2022, the date of the grantee's appointment as a director of Vaxart, Inc.